Some never get to the target dose because of side effects
Underlying Health Conditions: Individuals taking Wegovy often have underlying conditions like obesity, type 2 diabetes, or cardiovascular risk factors
Shakir and the team at North Fulton
Learn More About Retatrutide What is Retatrutide Retatrutide is a first-in-class synthetic peptide developed by Eli Lilly that simultaneously activates three hormone receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon that together govern appetite, metabolism, insulin sensitivity, energy expenditure, and fat oxidation
This consensus gives clinicians practical guidance to reduce risk, support individualized and collaborative care, and stresses the importance of continuing insulin therapy in patients with type 1 diabetes, despite euglycemia and normal A1C values